HTG MOLECULAR DIAGNOSTICS, INC Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Htg Molecular Diagnostics, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2022.
  • Htg Molecular Diagnostics, Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $137K, a 48.8% decline year-over-year.
  • Htg Molecular Diagnostics, Inc Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $643K, a 47.9% decline year-over-year.
  • Htg Molecular Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2022 was $774K, a 41.2% decline from 2021.
  • Htg Molecular Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2021 was $1.32M, a 16.9% decline from 2020.
  • Htg Molecular Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2020 was $1.58M, a 37% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $774K -$543K -41.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 $1.32M -$267K -16.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $1.58M +$428K +37% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $1.16M -$731K -38.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $1.89M +$452K +31.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-25
2017 $1.44M +$434K +43.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 $1M +$597K +147% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-23
2015 $405K +$220K +119% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-23
2014 $185K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.